<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>医学新闻</title><description>来自 News-Medical.Net - 来自世界各地的最新医学新闻和研究</description><link/>https://www.news-medical.net/<language> en-GB</language><item><title>研究证实 Kencur 提取物具有抗癌作用</title><description>您可能知道它是一种为菜肴增添风味的芳香香料，或者是一种缓解胃部不适的舒缓草药，但大阪都立大学的研究人员发现了有希望的发现，Kencur 是一种原产于东南亚的生姜科热带植物。 ，具有抗癌作用。</description><link/> https://www.news-medical.net/news/20230828/Study-confirms-the-anti-cancer-effects-of-Kencur-extract.aspx<comments> https://www.news-medical.net/news/20230828/Study-confirms-the-anti-cancer-effects-of-Kencur-extract.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=dc2257e7-c7c9-4546-9d23-dd247b3e7d0e</guid><pubDate> Mon, 28 Aug 2023 11:59:35 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/174318220-620x480.jpg" width="620"><media:description><![CDATA[Study confirms the anti-cancer effects of Kencur extract]]></media:description></media:content></item><item><title>患有 ARDS 的肥胖成人可能受益于 ECMO</title><description>美国国立卫生研究院支持的一项研究表明，肥胖成人在因呼吸衰竭而接受重症监护时，可能会受益于体外膜肺氧合 (ECMO)（一种先进的呼吸支持形式）的使用。</description><link/> https://www.news-medical.net/news/20230828/Obese-adults-with-ARDS-may-benefit-from-ECMO.aspx<comments> https://www.news-medical.net/news/20230828/Obese-adults-with-ARDS-may-benefit-from-ECMO.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=2b072902-8cc9-4c9a-a013-f8a7bf738079</guid><pubDate> Mon, 28 Aug 2023 11:55:26 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2017/3/Obesity-Jakub_Cejpek_ead0fb8492f0437f96e9fd842630990c-620x480.jpg" width="620"><media:description><![CDATA[Obese adults with ARDS may benefit from ECMO]]></media:description></media:content></item><item><title>全面的在线资源允许探索人类癌症突变特征和拓扑特征之间的相互作用</title><description>用于研究人类癌症突变特征与拓扑特征之间关系的在线资源。</description><link/> https://www.news-medical.net/news/20230828/A-compressive-online-resource-allows-for-the-exploration-of-interactions- Between-mutational-signatures-and-topographyal-features-across-人类癌症.aspx<comments> https://www.news-medical.net/news/20230828/A-compressive-online-resource-allows-for-the-exploration-of-interactions- Between-mutational-signatures-and-topographyal-features-across- human-cancer.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=89b07986-d4c9-49dd-a263-d8e4387a9d57</guid><pubDate> Mon, 28 Aug 2023 11:28:00 -0400</pubDate> <media:content expression="full" height="1125" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/images/news/ImageForNews_757408_16932361328747685.jpg" width="2000"><media:description><![CDATA[A comprehensive online resource allows for the exploration of interactions between mutational signatures and topographical features across human cancer]]></media:description></media:content></item><item><title>即使在药物洗脱支架时代，双联抗血小板治疗仍应是 PCI 的标准策略</title><description>经皮冠状动脉介入治疗（PCI）后使用药物洗脱支架进行普拉格雷单药治疗对于大出血并不优于双联抗血小板治疗（DAPT），但对于急性冠脉综合征（ACS）或高出血风险患者的心血管事件而言并不劣势。 HBR），根据今天在 ESC 2023 年大会热线会议上提出的最新突破性研究。</description><link/> https://www.news-medical.net/news/20230828/Dual-antiplatelet-therapy-should-remain-the-standard-strategy-for-PCI-even-in-the-drug-eluting-stent-era。 ASPX<comments> https://www.news-medical.net/news/20230828/Dual-antiplatelet-therapy-should-remain-the-standard-strategy-for-PCI-even-in-the-drug-eluting-stent-era。 aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=4137a79d-1482-48aa-9dc4-1419e0db2a8d</guid><pubDate> Mon, 28 Aug 2023 10:01:37 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Stent-620x480.jpg" width="620"><media:description><![CDATA[Dual-antiplatelet therapy should remain the standard strategy for PCI even in the drug-eluting stent era]]></media:description></media:content></item><item><title>尽管青春期参与度下降，但身体活动习惯普遍持续</title><description>最近的一项《科学报告》研究阐明了青春期期间根据青春期时间参与和停止体育活动的模式。</description><link/> https://www.news-medical.net/news/20230828/General-persistence-of-physical-activity-habits-despite-decline-in-participation-during-adolescent.aspx<comments> https://www.news-medical.net/news/20230828/General-persistence-of-physical-activity-habits-despite-decline-in-participation-during-adolescent.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=2674c8b7-e666-468a-b54c-975b1ce53b66</guid><pubDate> Mon, 28 Aug 2023 09:59:00 -0400</pubDate> <media:content expression="full" height="667" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/images/news/ImageForNews_757393_16932310563793657.jpg" width="1000"><media:description><![CDATA[General persistence of physical activity habits despite decline in participation during adolescence]]></media:description></media:content></item><item><title> CRT-D 升级可降低采用 RV 起搏的 HFrEF 患者的发病率和死亡率</title><description>与植入式心脏复律除颤器 (ICD) 相比，在特定的心力衰竭和射血分数降低 (HFrEF) 患者中，升级至除颤器心脏再同步治疗 (CRT-D) 可降低发病率和死亡率，并改善左心室 (LV) 逆重构根据今天在 ESC 2023 年大会上的热线会议上提出的最新突破性研究，间歇性或永久性右心室 (RV) 起搏。</description><link/> https://www.news-medical.net/news/20230828/CRT-D-upgrade-reduces-morbidity-and-mortality-in-HFrEF-病人-with-RV-pacing.aspx<comments> https://www.news-medical.net/news/20230828/CRT-D-upgrade-reduces-morbidity-and-mortality-in-HFrEF-病人-with-RV-pacing.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=6e764a6a-0d52-464a-91ef-882e8a6f0fa8</guid><pubDate> Mon, 28 Aug 2023 09:54:19 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2017/1/Anatomy_of_Human_Heart.-Liya_Graphics_5ac9d64765b747899bc4a9ef77468432-620x480.jpg" width="620"><media:description><![CDATA[CRT-D upgrade reduces morbidity and mortality in HFrEF patients with RV pacing]]></media:description></media:content></item><item><title>静脉注射羧基麦芽糖铁可降低缺铁患者心力衰竭住院的风险</title><description>据研究，与安慰剂相比，在患有心力衰竭且左心室射血分数降低或轻度降低的缺铁患者中，静脉注射羧基麦芽糖铁 (FCM) 与 52 周内总心血管住院和心血管死亡综合结果的风险降低相关。今天在 2023 年 ESC 大会的热线会议上介绍了最新研究成果。</description><link/> https://www.news-medical.net/news/20230828/Intravenous-ferric-carboxymaltose-linked-to-lower-risk-of-heart-failure-hospitalizations-in-iron-deficient-病人.aspx<comments> https://www.news-medical.net/news/20230828/Intravenous-ferric-carboxymaltose-linked-to-lower-risk-of-heart-failure-hospitalizations-in-iron-deficient-病人.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=c495c899-8d12-49c2-a3df-99293baae1a4</guid><pubDate> Mon, 28 Aug 2023 09:46:21 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2017/1/Anatomy_of_Human_Heart.-Liya_Graphics_5ac9d64765b747899bc4a9ef77468432-620x480.jpg" width="620"><media:description><![CDATA[Intravenous ferric carboxymaltose linked to lower risk of heart failure hospitalizations in iron-deficient patients]]></media:description></media:content></item><item><title> PROFID EHRA 试验评估 ICD 治疗对心肌梗死幸存者的潜在益处</title><description>对患有心力衰竭的心肌梗死幸存者常规植入植入式心脏复律除颤器（ICD）是否仍然是预防心源性猝死的充分疗法？</description><link/> https://www.news-medical.net/news/20230828/PROFID-EHRA-tri-to-assess-the-pottial-benefit-of-ICD-therapy-in-myocardial-infarction-survivors.aspx<comments> https://www.news-medical.net/news/20230828/PROFID-EHRA-tri-to-assess-the-pottial-benefit-of-ICD-therapy-in-myocardial-infarction-survivors.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=2b55ce82-17c0-44ed-a7d5-60cd5d63447c</guid><pubDate> Mon, 28 Aug 2023 09:40:07 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Defibrillator-620x480.jpg" width="620"><media:description><![CDATA[PROFID EHRA trial to assess the potential benefit of ICD therapy in myocardial infarction survivors]]></media:description></media:content></item><item><title>靶向线粒体相关程序性细胞死亡治疗年龄相关疾病的潜力</title><description>该综述总结了线粒体在与年龄相关的疾病进展中的参与，并强调了其作为这些疾病的治疗靶点的潜力。</description><link/> https://www.news-medical.net/news/20230828/The-pottial-of-targeting-mitochondria- Associated-programmed-cell-death-for-age-lated-disease-treatment.aspx<comments> https://www.news-medical.net/news/20230828/The-potential-of-targeting-mitochondria- Associated-programmed-cell-death-for-age-lated-disease-treatment.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=7217948a-6082-4024-9668-a76f73c242cf</guid><pubDate> Mon, 28 Aug 2023 09:30:00 -0400</pubDate> <media:content expression="full" height="667" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/images/news/ImageForNews_757383_16932292132953003.jpg" width="1000"><media:description><![CDATA[The potential of targeting mitochondria-associated programmed cell death for age-related disease treatment]]></media:description></media:content></item><item><title>试验评估行为和心理干预措施以减少乳腺癌治疗的心脏毒性作用</title><description>患有乳腺癌的女性将参加一项临床试验，检查行为和心理干预措施减少抗癌治疗对心脏损害的能力。</description><link/> https://www.news-medical.net/news/20230828/Trial-evaluates-behavioral-and-psychological-interventions-to-reduce-cardioknown-effects-of-breast-cancer-treatment.aspx<comments> https://www.news-medical.net/news/20230828/Trial-evaluates-behavioral-and-psychological-interventions-to-reduce-cardioknown-effects-of-breast-cancer-treatment.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=43a7c0a2-1b9a-4347-8b29-f9a30f68315c</guid><pubDate> Mon, 28 Aug 2023 09:23:35 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/91618146-620x480.jpg" width="620"><media:description><![CDATA[Trial evaluates behavioral and psychological interventions to reduce cardiotoxic effects of breast cancer treatment]]></media:description></media:content></item></channel></rss>